181 related articles for article (PubMed ID: 38183517)
1. Central nervous system clear cell meningioma: a systematic literature review.
Liang Q; Ge P; Liu Y; Zhu X; Lu S; Pan C; Ji Z; Wang Q; Wang Y
Neurosurg Rev; 2024 Jan; 47(1):35. PubMed ID: 38183517
[TBL] [Abstract][Full Text] [Related]
2. Clinical Features, Treatment, and Prognostic Factors of 56 Intracranial and Intraspinal Clear Cell Meningiomas.
Tao X; Dong J; Hou Z; Hao S; Zhang J; Wu Z; Liu B
World Neurosurg; 2018 Mar; 111():e880-e887. PubMed ID: 29325940
[TBL] [Abstract][Full Text] [Related]
3. Surgically resected skull base meningiomas demonstrate a divergent postoperative recurrence pattern compared with non-skull base meningiomas.
Mansouri A; Klironomos G; Taslimi S; Kilian A; Gentili F; Khan OH; Aldape K; Zadeh G
J Neurosurg; 2016 Aug; 125(2):431-40. PubMed ID: 26722844
[TBL] [Abstract][Full Text] [Related]
4. Intracranial Clear Cell Meningiomas: Study on Clinical Features and Predictors of Recurrence.
Zhang H; Ma L; Wang YB; Shu C; Kuang W; Huang YA; Dong LQ; Cheng GG
World Neurosurg; 2017 Jan; 97():693-700.e11. PubMed ID: 27744084
[TBL] [Abstract][Full Text] [Related]
5. Determining the role of adjuvant radiotherapy in the management of meningioma: a Surveillance, Epidemiology, and End Results analysis.
Reddy AK; Ryoo JS; Denyer S; McGuire LS; Mehta AI
Neurosurg Focus; 2019 Jun; 46(6):E3. PubMed ID: 31153148
[TBL] [Abstract][Full Text] [Related]
6. Intracranial clear cell meningioma: Clinical study with long-term follow-up in 24 patients.
Li J; Deng X; Zhang S; Wang Q; Cheng J; Li X; Ke D; Hui X
Clin Neurol Neurosurg; 2018 Dec; 175():74-83. PubMed ID: 30384120
[TBL] [Abstract][Full Text] [Related]
7. Epidemiology, characteristics, and prognostic factors of lymphoplasmacyte-rich meningioma: a systematic literature review.
Zhu X; Liu Y; Guo W; Liang Q; Pan C; Tan B; Yu Y
BMC Cancer; 2024 Jan; 24(1):110. PubMed ID: 38254159
[TBL] [Abstract][Full Text] [Related]
8. Extent of resection and survival outcomes in World Health Organization grade II meningiomas.
Soni P; Davison MA; Shao J; Momin A; Lopez D; Angelov L; Barnett GH; Lee JH; Mohammadi AM; Kshettry VR; Recinos PF
J Neurooncol; 2021 Jan; 151(2):173-179. PubMed ID: 33205354
[TBL] [Abstract][Full Text] [Related]
9. Prognostic Factors, Survival, and Treatment for Intracranial World Health Organization Grade II Chordoid Meningiomas and Clear-Cell Meningiomas.
Zhang GJ; Zhang YS; Zhang GB; Yan XJ; Li CB; Zhang LW; Li D; Wu Z; Zhang JT
World Neurosurg; 2018 Sep; 117():e57-e66. PubMed ID: 29859361
[TBL] [Abstract][Full Text] [Related]
10. Skull base atypical meningioma: long term surgical outcome and prognostic factors.
Wang YC; Chuang CC; Wei KC; Hsu YH; Hsu PW; Lee ST; Wu CT; Tseng CK; Wang CC; Chen YL; Jung SM; Chen PY
Clin Neurol Neurosurg; 2015 Jan; 128():112-6. PubMed ID: 25486076
[TBL] [Abstract][Full Text] [Related]
11. Utility of Neuronavigation in Intracranial Meningioma Resection: A Single-Center Retrospective Study.
Bir SC; Konar SK; Maiti TK; Thakur JD; Guthikonda B; Nanda A
World Neurosurg; 2016 Jun; 90():546-555.e1. PubMed ID: 26805681
[TBL] [Abstract][Full Text] [Related]
12. Spinal Clear Cell Meningiomas: Clinical Features and Factors Predicting Recurrence.
Zhang H; Ma L; Shu C; Dong LQ; Ma YQ; Zhou Y
World Neurosurg; 2020 Feb; 134():e1062-e1076. PubMed ID: 31765868
[TBL] [Abstract][Full Text] [Related]
13. Evaluating risk of recurrence in patients with meningioma.
Traylor JI; Plitt AR; Hicks WH; Mian TM; Mickey BE; Barnett SL
J Neurosurg; 2023 Mar; 138(3):621-628. PubMed ID: 36866795
[TBL] [Abstract][Full Text] [Related]
14. Survival in patients treated for anaplastic meningioma.
Moliterno J; Cope WP; Vartanian ED; Reiner AS; Kellen R; Ogilvie SQ; Huse JT; Gutin PH
J Neurosurg; 2015 Jul; 123(1):23-30. PubMed ID: 25859807
[TBL] [Abstract][Full Text] [Related]
15. Intracranial angiomatous meningiomas: A 15-year, multicenter study.
Ben Nsir A; Chabaane M; Krifa H; Jeme H; Hattab N
Clin Neurol Neurosurg; 2016 Oct; 149():111-7. PubMed ID: 27513979
[TBL] [Abstract][Full Text] [Related]
16. Clinical features and treatment of World Health Organization grade II and III meningiomas in childhood: report of 23 cases.
Wang XQ; Jiang CC; Zhao L; Gong Y; Hu J; Chen H
J Neurosurg Pediatr; 2012 Nov; 10(5):423-33. PubMed ID: 22938082
[TBL] [Abstract][Full Text] [Related]
17. Long-term surgical outcome and biological prognostic factors in patients with skull base meningiomas.
Ohba S; Kobayashi M; Horiguchi T; Onozuka S; Yoshida K; Ohira T; Kawase T
J Neurosurg; 2011 May; 114(5):1278-87. PubMed ID: 21166572
[TBL] [Abstract][Full Text] [Related]
18. Early adjuvant radiotherapy in the treatment of atypical meningioma.
Jenkinson MD; Waqar M; Farah JO; Farrell M; Barbagallo GM; McManus R; Looby S; Hussey D; Fitzpatrick D; Certo F; Javadpour M
J Clin Neurosci; 2016 Jun; 28():87-92. PubMed ID: 26775147
[TBL] [Abstract][Full Text] [Related]
19. Outcome of resection of WHO Grade II meningioma and correlation of pathological and radiological predictive factors for recurrence.
Nanda A; Bir SC; Konar S; Maiti T; Kalakoti P; Jacobsohn JA; Guthikonda B
J Clin Neurosci; 2016 Sep; 31():112-21. PubMed ID: 27427214
[TBL] [Abstract][Full Text] [Related]
20. Gross total resection and adjuvant radiotherapy most significant predictors of improved survival in patients with atypical meningioma.
Rydzewski NR; Lesniak MS; Chandler JP; Kalapurakal JA; Pollom E; Tate MC; Bloch O; Kruser T; Dalal P; Sachdev S
Cancer; 2018 Feb; 124(4):734-742. PubMed ID: 29131312
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
